Evidence map›Paper›PMID 29177551›Full record

ReviewAnnals of hematology2018

Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

M Schmidt-Hieber, J Bierwirth, D Buchheidt, O A Cornely, M Hentrich, G Maschmeyer, E Schalk, J J Vehreschild, Maria J G T Vehreschild, AGIHO Working Group

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Case reports in oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

M Schmidt-HieberClinic for Hematology, Oncology, Tumor Immunology and Palliative Care, HELIOS Klinikum Berlin-Buch, Berlin, Germany.
J BierwirthDeutsches Beratungszentrum für Hygiene, BZH GmbH, Freiburg, Germany.
D Buchheidt3rd Department of Internal Medicine - Hematology and Oncology - Mannheim University Hospital, University of Heidelberg, Heidelberg, Germany.
O A Cornely1st Department of Internal Medicine, University of Cologne, Cologne, Germany.
M HentrichDepartment III for Internal Medicine, Hematology and Oncology, Rotkreuzklinikum München, Munich, Germany.
G MaschmeyerDepartment of Hematology, Oncology and Palliative Care, Ernst-von-Bergmann Klinikum, Potsdam, Germany.
E SchalkDepartment of Hematology and Oncology, Medical Center, Otto-von-Guericke University, Magdeburg, Germany.
J J Vehreschild1st Department of Internal Medicine, University of Cologne, Cologne, Germany.
Maria J G T Vehreschild1st Department of Internal Medicine, University of Cologne, Cologne, Germany. maria.vehreschild@uk-koeln.de.
AGIHO Working Group
University of Cologne · DEDeutsches Beratungszentrum für Hygiene · DEGerman Center for Infection Research · DEHeidelberg University · DEHelios Hospital Berlin-Buch · DEKlinikum Ernst von Bergmann · DERotkreuzklinikum München · DE

Funding

AGIHO no number
6 · The paper itself

Abstract

Cancer patients frequently suffer from gastrointestinal complications. In this manuscript, we update our 2013 guideline on the diagnosis and management of gastrointestinal complications in adult cancer patients by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). An expert group was put together by the AGIHO to update the existing guideline. For each sub-topic, a literature search was performed in PubMed, Medline, and Cochrane databases, and strengths of recommendation and the quality of the published evidence for major therapeutic strategies were categorized using the 2015 European Society for Clinical Microbiology and Infectious Diseases (ESCMID) criteria. Final recommendations were approved by the AGIHO plenary conference. Recommendations were made with respect to non-infectious and infectious gastrointestinal complications. Strengths of recommendation and levels of evidence are presented. A multidisciplinary approach to the diagnosis and management of gastrointestinal complications in cancer patients is mandatory. Evidence-based recommendations are provided in this updated guideline.

Indexed as

AdultCommunicable DiseasesGastrointestinal DiseasesGermanyHematologyHumansMedical OncologyNeoplasmsPractice Guidelines as TopicSocieties, MedicalAbdominal complicationsCancerChemotherapyColitisDiarrheaInfection

Identifiers

PMID29177551
PMCPMC5748412
OpenAlexW2768892915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.